R. Hofmeister

发表

Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response

S. Weiler, Jian Ding, W. Schamel, 2019, Nature Communications.

BiTEs: bispecific antibody constructs with unique anti-tumor activity.

P. Kufer, P. Baeuerle, R. Hofmeister, 2005, Drug discovery today.

A critical role for interleukin‐1 receptor accessory protein in interleukin‐1 signaling

W. Falk, R. Hofmeister, H. Wesche, 1997, European journal of immunology.

Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells.

P. Kufer, S. Offner, P. Baeuerle, 2006, Molecular immunology.

Implications of T cell receptor biology on the development of new T cell therapies for cancer.

W. Schamel, P. Baeuerle, D. Getts, 2020, Immunotherapy.

CD19-/CD3-bispecific antibody of the BiTE class is far superior to tandem diabody with respect to redirected tumor cell lysis.

P. Hoffmann, P. Kufer, M. Mølhøj, 2007, Molecular immunology.

MT110: a novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors.

R. Kimmig, P. Kufer, R. Lutterbuese, 2006, Molecular immunology.

Serial killing of tumor cells by cytotoxic T cells redirected with a CD19‐/CD3‐bispecific single‐chain antibody construct

P. Hoffmann, P. Baeuerle, C. Itin, 2005, International journal of cancer.

Humans and Regulatory T Cells in Tumors from Mice + Defines a Stable Population of CD4 Foxp3 Cutting Edge: Epigenetic Regulation of

S. Takai, H. Sabzevari, R. Hofmeister, 2014 .

Activation of Acid Sphingomyelinase by Interleukin-1 (IL-1) Requires the IL-1 Receptor Accessory Protein*

W. Falk, M. Krönke, K. Bernardo, 1997, The Journal of Biological Chemistry.

Generation of Macrophages from Early T Progenitors In Vitro1

S. Durum, Myung-Koo Lee, Youngsoo Kim, 2001, The Journal of Immunology.

Identification of Essential Regions in the Cytoplasmic Tail of Interleukin-1 Receptor Accessory Protein Critical for Interleukin-1 Signaling*

W. Falk, R. Hofmeister, S. Gabler, 2002, The Journal of Biological Chemistry.

Distinct Regions of the Interleukin-7 Receptor Regulate Different Bcl2 Family Members

H. Young, Q. Jiang, W. Li, 2004, Molecular and Cellular Biology.

The effect of dexamethasone on polyclonal T cell activation and redirected target cell lysis as induced by a CD19/CD3-bispecific single-chain antibody construct

P. Kufer, J. Suzich, P. Baeuerle, 2007, Cancer Immunology, Immunotherapy.

The Mammalian Calcium-binding Protein, Nucleobindin (CALNUC), Is a Golgi Resident Protein

M. Farquhar, J. Michael McCaffery, L. de Vries, 1998, The Journal of cell biology.

Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa.

R. Knuechel, G. Rogler, J. Schölmerich, 1998, Gastroenterology.

Synthetic T cell receptor-based lymphocytes for cancer therapy.

A. Quintás-Cardama, D. Getts, R. Hofmeister, 2019, Advanced drug delivery reviews.

Interleukin-7: physiological roles and mechanisms of action.

K. Muegge, A. Khaled, S. Durum, 1999, Cytokine & growth factor reviews.

Survey Interleukin-7: physiological roles and mechanisms of action

K. Muegge, S. Durum, E. Rajnavölgyi, 1999 .

Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH.

K. Muegge, A. Khaled, S. Durum, 1999, Proceedings of the National Academy of Sciences of the United States of America.

H. Sabzevari, S. Bennuru, T. Nutman, 2018, PLoS neglected tropical diseases.

Cutting Edge: Epigenetic Regulation of Foxp3 Defines a Stable Population of CD4+ Regulatory T Cells in Tumors from Mice and Humans

S. Takai, Dong Zhang, H. Sabzevari, 2015, The Journal of Immunology.

Overexpression of CALNUC (Nucleobindin) Increases Agonist and Thapsigargin Releasable Ca2+ Storage in the Golgi

R. Tsien, M. Farquhar, R. Hofmeister, 1999, The Journal of cell biology.

Mesothelin-targeting T cells bearing a novel T cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumors

Guangwu Guo, P. Baeuerle, Greg M. Delgoffe, 2023, Oncoimmunology.

Exchanging human Fcγ1 with murine Fcγ2a highly potentiates anti-tumor activity of anti-EpCAM antibody adecatumumab in a syngeneic mouse lung metastasis model

P. Baeuerle, R. Hofmeister, B. Schlereth, 2007, Cancer Immunology, Immunotherapy.

Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells.

P. Kufer, R. Lutterbuese, P. Kiener, 2009, Leukemia research.

Preparation of Golgi subfractions with free‐solution isotachophoresis: Analysis of sphingomyelin synthesis in Golgi subfractions from rat liver

R. Hofmeister, A. Böttcher, Gert Schmitz, 1998, Electrophoresis.

Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response

S. Weiler, Jian Ding, W. Schamel, 2019, Nature Communications.

Evidence for an intracellular activation loop in the IL-1 system.

W. Falk, D. Männel, R. Hofmeister, 1995, Journal of inflammation.

Response to Comment on “Cutting Edge: Epigenetic Regulation of Foxp3 Defines a Stable Population of CD4+ Regulatory T cells in Tumors from Mice and Humans”

R. Hofmeister, N. Wilson, J. Waight, 2015, The Journal of Immunology.

The internalized interleukin-1 activation complex in fibroblasts localizes to the Golgi apparatus.

W. Falk, P. Krammer, R. Hofmeister, 1995, Journal of inflammation.